益佰制药(600594)资产负债表_股票行情中心

资产负债表

报告期	2026-03-31	2025-12-31	2025-09-30	2025-06-30
公司类型	通用	通用	通用	通用
流动资产:
货币资金	489,897,047.83	447,132,630.97	593,695,601.81	695,146,756.66
应收票据及应收账款	327,342,398.14	376,974,397.68	378,549,822.5	410,986,471.31
其中：应收票据	197,334,336.27	209,636,740.01	204,412,969.62	220,189,595.8
应收账款	130,008,061.87	167,337,657.67	174,136,852.88	190,796,875.51
预付款项	11,439,008.4	8,533,498.69	23,647,927.94	22,412,623.41
其他应收款合计	37,923,837.87	31,882,798.42	30,798,884.22	21,140,407.32
其中:应收利息	-	-	32,591.03	-
存货	540,242,201.26	546,902,616.32	545,495,239.8	571,511,212.81
一年内到期的非流动资产	1,739,237.01	-	-	-
其他流动资产	34,495,593.64	36,291,808.28	57,820,739.42	57,371,202.87
流动资产合计	1,443,079,324.15	1,447,717,750.36	1,630,008,215.69	1,778,568,674.38
非流动资产:
长期应收款	6,488,883.11	-	-	-
长期股权投资	34,682,969.45	34,802,100.76	34,703,753.79	34,588,846.78
其他权益工具投资	1,093,940.44	1,093,625.97	1,290,618.61	1,330,862.51
固定资产	1,405,959,477.21	1,445,207,657.59	1,476,529,492.01	1,533,935,870.96
在建工程	2,745,604.41	2,180,557.22	6,303,210.37	4,472,266.08
生产性生物资产	24,224,255.74	19,594,943.11	16,597,724.12	15,510,435.52
使用权资产	5,627,964.19	7,126,500.79	23,904,263.2	25,775,467.96
无形资产	308,259,414.67	312,294,392.62	309,700,848.79	315,187,760.09
商誉	-	-	131,262,741.12	131,262,741.12
长期待摊费用	73,089,685.66	77,821,638.61	89,959,878.83	94,830,295.71
递延所得税资产	76,137,290.86	77,813,654.72	100,701,036.12	98,582,418.15
其他非流动资产	16,837,396.93	16,182,841.01	17,226,738.93	18,275,899.22
非流动资产合计	1,955,146,882.67	1,994,117,912.4	2,208,180,305.89	2,273,752,864.1
资产总计	3,398,226,206.82	3,441,835,662.76	3,838,188,521.58	4,052,321,538.48
流动负债:
短期借款	438,870,292.26	413,928,393.94	413,894,610.61	510,911,907.83
应付票据及应付账款	82,595,022.99	102,985,998.77	91,684,492.89	100,722,423.99
应付账款	82,595,022.99	102,985,998.77	91,684,492.89	100,722,423.99
合同负债	25,548,095.81	24,278,195.27	21,012,907.93	35,630,377.56
应付职工薪酬	27,704,404.59	45,505,503.51	35,953,417.1	31,644,724.43
应交税费	21,141,307.4	17,690,297.99	24,368,447.87	24,794,489.61
其他应付款合计	127,045,706.33	114,789,710.54	78,635,196.16	82,074,892.37
其中:应付利息	171,203.52	171,203.52	171,203.52	171,203.52
一年内到期的非流动负债	123,806,918.89	188,168,033.53	202,011,659.75	202,419,148.74
其他流动负债	1,239,122.66	1,529,319.41	875,995.47	2,617,914.27
流动负债合计	847,950,870.93	908,875,452.96	868,436,727.78	990,815,878.8
非流动负债:
长期借款	150,189,169.13	100,139,169.12	229,558,002.95	249,986,836.78
租赁负债	2,278,920.07	2,359,153.8	20,650,392.79	20,570,171.89
长期应付款	37,000,000	37,555,000	80,000,000	80,000,000
预计负债	2,162,632.07	2,201,492.07	59,497.51	189,875.48
递延收益	85,568,521.43	88,165,024.01	90,776,664.05	93,514,674.25
递延所得税负债	31,435,169.94	31,936,395.36	33,243,435.44	33,478,217.51
非流动负债合计	308,634,412.64	262,356,234.36	454,287,992.74	477,739,775.91
负债合计	1,156,585,283.57	1,171,231,687.32	1,322,724,720.52	1,468,555,654.71
所有者权益(或股东权益):
实收资本(或股本)	791,927,400	791,927,400	791,927,400	791,927,400
资本公积	681,591,861.64	681,591,861.64	653,836,676.92	653,836,676.92
减:库存股	25,004,481.14	25,004,481.14	25,004,481.14	25,004,481.14
其他综合收益	282,060.79	281,824.94	429,569.42	459,752.34
盈余公积	314,569,579.33	314,569,579.33	314,569,579.33	314,569,579.33
未分配利润	394,895,786.7	424,420,689.59	667,420,393.75	734,080,957.95
归属于母公司股东权益合计	2,158,262,207.32	2,187,786,874.36	2,403,179,138.28	2,469,869,885.4
少数股东权益	83,378,715.93	82,817,101.08	112,284,662.78	113,895,998.37
股东权益合计	2,241,640,923.25	2,270,603,975.44	2,515,463,801.06	2,583,765,883.77
负债和股东权益合计	3,398,226,206.82	3,441,835,662.76	3,838,188,521.58	4,052,321,538.48
公告日期	2026-04-23	2026-04-23	2025-10-30	2025-08-21
审计意见(境内)		标准无保留意见

流通市值：32.07亿			总市值：32.07亿
流通股本：7.92亿			总股本：7.92亿